Percutaneous ethanol injection into parathyroid adenomas: mid- and long-term results

被引:17
作者
Cercueil, JP
Jacob, D
Verges, B
Holtzmann, P
Lerais, JM
Krause, D
机构
[1] CHU Le Bocage, Dept Imaging, F-21034 Dijon, France
[2] CHU Le Bocage, Dept Endocrinol, F-21034 Dijon, France
关键词
parathyroid adenoma; ethanol injection; hyperparathyroidism; interventional radiology;
D O I
10.1007/s003300050587
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The aim of this study was to evaluate mid- and long-term results of ultrasonically guided ethanol injection into parathyroid adenomas. From 1988 to 1996, 27 patients (mean age 77 +/- 13 years) were treated for parathyroid adenomas by percutaneous ethanol injection. The survey included clinical information, plasma calcium, phosphorus and PTH (1-84) evaluation. Follow-up lasted 22.6 +/- 10 months. No major complications were observed for 63 ethanol injections. Biochemical recovery was 58%, biochemical improvement at 3 months was 33%, and failure was 7%. Four of 15 cured patients presented a recurrence of the disease 1 or 2 years after the first treatment. Ultrasonically guided ethanol injection can be useful in the treatment of parathyroid adenomas when surgery. A regular biochemical survey is necessary so that recurrences can be recognized and treated at an early stage.
引用
收藏
页码:1565 / 1569
页数:5
相关论文
共 20 条
[1]   Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases [J].
Bennedbaek, FN ;
Karstrup, S ;
Hegedus, L .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 136 (03) :240-250
[2]  
CHICOT JP, 1995, SURGERY, V117, P397
[3]   CHEMICAL PARATHYROIDECTOMY FOR RECURRENCE OF SECONDARY HYPERPARATHYROIDISM [J].
GIANGRANDE, A ;
CASTIGLIONI, A ;
SOLBIATI, L ;
BALLARATI, E ;
CALIGARA, F .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (03) :421-426
[4]  
IRVIN GL, 1987, SURGERY, V102, P898
[5]   NONSURGICAL TREATMENT OF PRIMARY HYPERPARATHYROIDISM WITH SONOGRAPHICALLY GUIDED PERCUTANEOUS INJECTION OF ETHANOL - RESULTS IN A SELECTED SERIES OF PATIENTS [J].
KARSTRUP, S ;
HOLM, HH ;
GLENTHOJ, A ;
HEGEDUS, L .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1990, 154 (05) :1087-1090
[6]   ULTRASONICALLY GUIDED CHEMICAL PARATHYROIDECTOMY IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM - A FOLLOW-UP-STUDY [J].
KARSTRUP, S ;
HEGEDUS, L ;
HOLM, HH .
CLINICAL ENDOCRINOLOGY, 1993, 38 (05) :523-530
[7]   ULTRASONICALLY GUIDED PERCUTANEOUS INACTIVATION OF PARATHYROID TUMORS [J].
KARSTRUP, S ;
HOLM, HH ;
TORPPEDERSEN, S ;
HEGEDUS, L .
BRITISH JOURNAL OF RADIOLOGY, 1987, 60 (715) :667-670
[8]   ULTRASOUND-GUIDED CHEMICAL PARATHYROIDECTOMY IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM - A PROSPECTIVE-STUDY [J].
KARSTRUP, S ;
TRANSBOL, I ;
HOLM, HH ;
GLENTHOJ, A ;
HEGEDUS, L .
BRITISH JOURNAL OF RADIOLOGY, 1989, 62 (744) :1037-1042
[9]   ACUTE CHANGE IN PARATHYROID FUNCTION IN PRIMARY HYPERPARATHYROIDISM FOLLOWING ULTRASONICALLY GUIDED ETHANOL INJECTION INTO SOLITARY PARATHYROID ADENOMAS [J].
KARSTRUP, S ;
HEGEDUS, L ;
HOLM, HH .
ACTA ENDOCRINOLOGICA, 1993, 129 (05) :377-380
[10]   PRIMARY HYPERPARATHYROIDISM - A REVIEW OF THE LONG-TERM SURGICAL AND NONSURGICAL MORBIDITIES AS A BASIS FOR A RATIONAL APPROACH TO TREATMENT [J].
LAFFERTY, FW ;
HUBAY, CA .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (04) :789-796